Histotripsy for mCRC liver mets: Dr. Hernandez (2023)
On December 20, 2023, Dr. Hernandez discussed the newly FDA-approved treatment of Histotripsy in the treatment of mCRC liver metasteses within a week of performing the first time use of this novel therapy after FDA-Approval in the US. He describes the history of the therapy, what it entails, why and for what conditions it is applicable and future research ideas.
Warning: Graphic surgical images at 13:00 minute mark.
COLONTOWN University has so much more to offer, from DocTalk videos with CRC experts to easy-to-understand biomarker test breakdowns. We’re here for you! See our list of Learning Centers here.